Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03458988
Other study ID # 2017-01570
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 27, 2018
Est. completion date December 31, 2020

Study information

Verified date November 2021
Source University Hospital Inselspital, Berne
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To prove the novel device is able to reliably detect pulsatility in patients with CF-VADs and to analyze whether pre-programmed intrinsic pulsatility of the 3rd generation CF-VADs can also be picked up. The study is not designed to measure blood pressure. Should this pilot study be successful in detecting enough pulsatility a follow-up study would then try to transfer the results into blood-pressure values with the help of comparators in order to identify an easier and more reliable method to measure BP in CF-VAD patients. .


Description:

The number of patients supported by left ventricular assist device (LVAD) is increasing as durable mechanical support has become widely available for end stage heart failure as destination therapy and as bridge to transplantation. The accurate measurement of blood pressure (BP) as well as the recognition and management of hypertension in patients with LVADs is an essential component of optimal clinical care. Hypertension is an established long-term risk factor for cardiovascular disease. The measurement of BP and the management of hypertension in patients with CF-VADs can present unique challenges. Patients with LVADs often do not have a palpable pulse, and therefore traditional BP measurement by auscultation or automated cuff is less reliable. Conventional occlusive BP measurement is able to to pick up signals in approximately 50% of cases due to coincidental phases of pulsatility. The arterial line is the gold standard, but is an invasive procedure and not practical for routine outpatient use. Although efforts are underway to identify an easier and more reliable method to measure ambulatory BP in these patients not one has been able to match the quality of an invasive arterial line.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date December 31, 2020
Est. primary completion date October 31, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Patients carrying one of the two third generation CF-VADS (Heartware HVAD, Heartmate 3) - Patients >18y - Good understanding of written and oral German - Signed informed consent - Scheduled for routine outpatient appointment. Exclusion Criteria: - In the population of the outpatient clinic's CV-LVAD patients no known exclusion criteria exists

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Blood-pressure measuring (Nellcorâ„¢ Adult SpO2 Sensor)
Data will be acquired for 10 minutes with a reusable off the shelf adult SpO2 sensor. The Nellcorâ„¢ Adult SpO2 Sensor, model DS-100A, is indicated for use when continuous noninvasive arterial oxygen saturation and pulse rate monitoring are required for patients weighing greater than 40 kg.

Locations

Country Name City State
Switzerland University Hospital Bern Bern

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Inselspital, Berne

Country where clinical trial is conducted

Switzerland, 

References & Publications (2)

Lampert BC, Eckert C, Weaver S, Scanlon A, Lockard K, Allen C, Kunz N, Bermudez C, Bhama JK, Shullo MA, Kormos RL, Dew MA, Teuteberg JJ. Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events. Ann Thorac Surg. 2014 Jan;97(1):139-46. doi: 10.1016/j.athoracsur.2013.07.069. Epub 2013 Sep 25. — View Citation

Saeed O, Jermyn R, Kargoli F, Madan S, Mannem S, Gunda S, Nucci C, Farooqui S, Hassan S, Mclarty A, Bloom M, Zolty R, Shin J, D'Alessandro D, Goldstein DJ, Patel SR. Blood pressure and adverse events during continuous flow left ventricular assist device support. Circ Heart Fail. 2015 May;8(3):551-6. doi: 10.1161/CIRCHEARTFAILURE.114.002000. Epub 2015 Apr 13. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary RR (Riva Rocci, indirect blood pressure measurement) in LVAD Detect pulsatility in CF-VAD (Continuous flow- ventricular assist device) patients sufficient to calculate comprehensible blood-pressure values in future follow-up studies 10 min blood measuring
See also
  Status Clinical Trial Phase
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT04377854 - Prognostic Value of BNP in MCS - a 25 Year Follow up Study
Terminated NCT03346278 - Text Message Intervention to Improve Cardiac Rehab Participation N/A
Completed NCT01477528 - Study of Reduced Anti-coagulation/Anti-platelet Therapy in Patients With the HeartMate II Left Ventricular Assist System (LVAS) (TRACE)
Completed NCT01485666 - Thoratec's Reduce Driveline Trauma Through Stabilization and Exit Site Management Study
Completed NCT03143569 - Ventricular Assist Device Anti-Factor Xa (VAD ANTIX) Monitoring Study: a Prospective Randomized Feasibility Trial N/A
Completed NCT03217331 - CRD-102 for Right Heart Failure in Patients With Left Ventricular Assist Devices Phase 1/Phase 2
Recruiting NCT03583970 - Veno-arterial Extracorporeal Membrane Oxygenation Prior to Left Ventricular Assist Device Implantation.
Withdrawn NCT05916612 - Influence of Right Ventricular Function on Changes in Exercise Capacity After LVAD
Recruiting NCT04205760 - Preoperative Nutritional Optimization and Physical Exercise for Patients Scheduled for Elective Implantation for a Left-Ventricular Assist Device Phase 3
Terminated NCT04264182 - STandardized Ultra-conservative Or Physician-directed ICD Programming for Continuous Flow LVAD Support N/A
Withdrawn NCT01642927 - Pulse Wave Analysis in Advanced Heart Failure
Completed NCT05063006 - Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device N/A
Completed NCT03636815 - The Effect of Physical Therapy Intervention in Patients With Left Ventricular Assistive Device on Physical Function
Recruiting NCT04423562 - PROgnostic Value of Exercise Capacity Measured as Peak Oxygen Uptake (pVO2) in Recipients of Left Ventricular Assist Devices